Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers

Abstract Along with early-onset cancers, multiple primary cancers (MPCs) are likely resulting from increased genetic susceptibility; however, the associated predisposition genes or prevalence of the pathogenic variants genes in MPC patients are often unknown. We screened 71 patients with MPC of the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yoon Young Choi, Su-Jin Shin, Jae Eun Lee, Lisa Madlensky, Seung-Tae Lee, Ji Soo Park, Jeong-Hyeon Jo, Hyunki Kim, Daniela Nachmanson, Xiaojun Xu, Sung Hoon Noh, Jae-Ho Cheong, Olivier Harismendy
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7aa2118e78dc497482f0ca5b1ba90ee5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7aa2118e78dc497482f0ca5b1ba90ee5
record_format dspace
spelling oai:doaj.org-article:7aa2118e78dc497482f0ca5b1ba90ee52021-12-02T16:26:30ZPrevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers10.1038/s41598-021-94292-42045-2322https://doaj.org/article/7aa2118e78dc497482f0ca5b1ba90ee52021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94292-4https://doaj.org/toc/2045-2322Abstract Along with early-onset cancers, multiple primary cancers (MPCs) are likely resulting from increased genetic susceptibility; however, the associated predisposition genes or prevalence of the pathogenic variants genes in MPC patients are often unknown. We screened 71 patients with MPC of the stomach, colorectal, and endometrium, sequencing 65 cancer predisposition genes. A subset of 19 patients with early-onset MPC of stomach and colorectum were further evaluated for variants in cancer related genes using both normal and tumor whole exome sequencing. Among 71 patients with MPCs, variants classified to be pathogenic were observed in 15 (21.1%) patients and affected Lynch Syndrome (LS) genes: MLH1 (n = 10), MSH6 (n = 2), PMS2 (n = 2), and MSH2 (n = 1). All carriers had tumors with high microsatellite instability and 13 of them (86.7%) were early-onset, consistent with LS. In 19 patients with early-onset MPCs, loss of function (LoF) variants in RECQL5 were more prevalent in non-LS MPC than in matched sporadic cancer patients (OR = 31.6, 2.73–1700.6, p = 0.001). Additionally, there were high-confidence LoF variants at FANCG and CASP8 in two patients accompanied by somatic loss of heterozygosity in tumor, respectively. The results suggest that genetic screening should be considered for synchronous cancers and metachronous MPCs of the LS tumor spectrum, particularly in early-onset. Susceptibility variants in non-LS genes for MPC patients may exist, but evidence for their role is more elusive than for LS patients.Yoon Young ChoiSu-Jin ShinJae Eun LeeLisa MadlenskySeung-Tae LeeJi Soo ParkJeong-Hyeon JoHyunki KimDaniela NachmansonXiaojun XuSung Hoon NohJae-Ho CheongOlivier HarismendyNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yoon Young Choi
Su-Jin Shin
Jae Eun Lee
Lisa Madlensky
Seung-Tae Lee
Ji Soo Park
Jeong-Hyeon Jo
Hyunki Kim
Daniela Nachmanson
Xiaojun Xu
Sung Hoon Noh
Jae-Ho Cheong
Olivier Harismendy
Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers
description Abstract Along with early-onset cancers, multiple primary cancers (MPCs) are likely resulting from increased genetic susceptibility; however, the associated predisposition genes or prevalence of the pathogenic variants genes in MPC patients are often unknown. We screened 71 patients with MPC of the stomach, colorectal, and endometrium, sequencing 65 cancer predisposition genes. A subset of 19 patients with early-onset MPC of stomach and colorectum were further evaluated for variants in cancer related genes using both normal and tumor whole exome sequencing. Among 71 patients with MPCs, variants classified to be pathogenic were observed in 15 (21.1%) patients and affected Lynch Syndrome (LS) genes: MLH1 (n = 10), MSH6 (n = 2), PMS2 (n = 2), and MSH2 (n = 1). All carriers had tumors with high microsatellite instability and 13 of them (86.7%) were early-onset, consistent with LS. In 19 patients with early-onset MPCs, loss of function (LoF) variants in RECQL5 were more prevalent in non-LS MPC than in matched sporadic cancer patients (OR = 31.6, 2.73–1700.6, p = 0.001). Additionally, there were high-confidence LoF variants at FANCG and CASP8 in two patients accompanied by somatic loss of heterozygosity in tumor, respectively. The results suggest that genetic screening should be considered for synchronous cancers and metachronous MPCs of the LS tumor spectrum, particularly in early-onset. Susceptibility variants in non-LS genes for MPC patients may exist, but evidence for their role is more elusive than for LS patients.
format article
author Yoon Young Choi
Su-Jin Shin
Jae Eun Lee
Lisa Madlensky
Seung-Tae Lee
Ji Soo Park
Jeong-Hyeon Jo
Hyunki Kim
Daniela Nachmanson
Xiaojun Xu
Sung Hoon Noh
Jae-Ho Cheong
Olivier Harismendy
author_facet Yoon Young Choi
Su-Jin Shin
Jae Eun Lee
Lisa Madlensky
Seung-Tae Lee
Ji Soo Park
Jeong-Hyeon Jo
Hyunki Kim
Daniela Nachmanson
Xiaojun Xu
Sung Hoon Noh
Jae-Ho Cheong
Olivier Harismendy
author_sort Yoon Young Choi
title Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers
title_short Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers
title_full Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers
title_fullStr Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers
title_full_unstemmed Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers
title_sort prevalence of cancer susceptibility variants in patients with multiple lynch syndrome related cancers
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/7aa2118e78dc497482f0ca5b1ba90ee5
work_keys_str_mv AT yoonyoungchoi prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
AT sujinshin prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
AT jaeeunlee prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
AT lisamadlensky prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
AT seungtaelee prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
AT jisoopark prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
AT jeonghyeonjo prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
AT hyunkikim prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
AT danielanachmanson prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
AT xiaojunxu prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
AT sunghoonnoh prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
AT jaehocheong prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
AT olivierharismendy prevalenceofcancersusceptibilityvariantsinpatientswithmultiplelynchsyndromerelatedcancers
_version_ 1718384060341944320